Product/Composition:- | Palonosetron |
---|---|
Strength:- | 0.25 mg/5 mL (0.05 mg/mL) |
Form:- | IV Injection |
Reference Brands:- | Aloxi® (US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Palonosetron Injection is a long-acting antiemetic used to prevent CINV and PONV, available as 0.25 mg/5 mL and 0.075 mg/mL IV doses. Marketed under Aloxi® in the US and EU, it offers extended protection and is ideal for oncology settings. GMP-compliant and available in both branded and generic forms, Palonosetron is a reliable choice for pharma partners across Europe and North America.
Palonosetron Injection is a next-generation 5-HT3 receptor antagonist used to prevent chemotherapy-induced and post-operative nausea and vomiting (CINV & PONV). Known for its long half-life and superior efficacy, Palonosetron provides extended protection against both acute and delayed emesis. It is available in 0.25 mg/5 mL and 0.075 mg/mL IV formulations, ideal for hospital and oncology settings. Marketed under Aloxi® in the US and EU, and also offered in generic form, it is manufactured under GMP-certified conditions. Palonosetron is a preferred antiemetic for pharmaceutical distributors seeking reliable oncology support across Europe and North America.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications